These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1699278)

  • 1. Fludarabine phosphate: an effective therapy for lymphoid malignancies.
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-78. PubMed ID: 1699278
    [No Abstract]   [Full Text] [Related]  

  • 2. Fludarabine phosphate--looking forward.
    Cheson BD
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):1-2. PubMed ID: 1699277
    [No Abstract]   [Full Text] [Related]  

  • 3. Fludarabine phosphate in chronic lymphoproliferative diseases. The French Group on CLL.
    Binet JL
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):5-7. PubMed ID: 7685518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive phase I and II clinical investigation of fludarabine phosphate.
    Grever M; Leiby J; Kraut E; Metz E; Neidhart J; Balcerzak S; Malspeis L
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):39-48. PubMed ID: 1699282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of fludarabine phosphate (Fludara) to treat chronic B-cell lymphocytic leukemia and non-Hodgkin's lymphoma resistant to standard chemotherapy].
    Gershanovich ML; Zaritskiĭ AIu; Medvedeva NV; Abdulkadyrov KM; Samuskevich IG; Beresneva IA
    Vopr Onkol; 1998; 44(6):696-700. PubMed ID: 10087967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine shows promise for some leukemia patients.
    Oncology (Williston Park); 1989 Mar; 3(3):14. PubMed ID: 2484283
    [No Abstract]   [Full Text] [Related]  

  • 7. Fludarabine phosphate therapy in other lymphoid malignancies.
    Kantarjian HM; Redman JR; Keating MJ
    Semin Oncol; 1990 Oct; 17(5 Suppl 8):66-70. PubMed ID: 1699285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fludarabine in the treatment of chronic lymphocytic leukemia and other lymphoproliferative disorders].
    Pawelski S
    Acta Haematol Pol; 1995; 26(3):263-8. PubMed ID: 8525771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fludarabine phosphate in lymphoma: an important new therapeutic agent.
    McLaughlin P; Robertson LE; Keating MJ
    Cancer Treat Res; 1996; 85():3-14. PubMed ID: 9043771
    [No Abstract]   [Full Text] [Related]  

  • 10. Fludarabine phosphate in the treatment of chronic lymphocytic leukemia: biology, clinical impact, and future directions.
    Robertson LE; Keating MJ
    Cancer Treat Res; 1993; 64():105-19. PubMed ID: 7680874
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of oral fludarabine phosphate in previously untreated patients with chronic lymphocytic leukemia.
    Rossi JF; van Hoof A; de Boeck K; Johnson SA; Bron D; Foussard C; Lister TA; Berthou C; Kramer MH; Littlewood TJ; Marcus RE; Deconinck E; Montillo M; Guibon O; Tollerfield SM
    J Clin Oncol; 2004 Apr; 22(7):1260-7. PubMed ID: 15051774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fludarabine in chronic leukaemia.
    Astrow AB
    Lancet; 1996 May; 347(9013):1420-1. PubMed ID: 8676619
    [No Abstract]   [Full Text] [Related]  

  • 13. Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma.
    Rodriguez G
    Invest New Drugs; 1994; 12(2):75-92. PubMed ID: 7532163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fludarabine in the treatment of lymphoproliferative malignancies.
    Feldman EJ; Keating MJ
    Cancer Invest; 1993; 11(3):314-8. PubMed ID: 8485654
    [No Abstract]   [Full Text] [Related]  

  • 15. Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.
    Foran JM; Rohatiner AZ; Coiffier B; Barbui T; Johnson SA; Hiddemann W; Radford JA; Norton AJ; Tollerfield SM; Wilson MP; Lister TA
    J Clin Oncol; 1999 Feb; 17(2):546-53. PubMed ID: 10080598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fludarabine monophosphate: a potentially useful agent in chronic lymphocytic leukemia.
    Grever MR; Kopecky KJ; Coltman CA; Files JC; Greenberg BR; Hutton JJ; Talley R; Von Hoff DD; Balcerzak SP
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):457-9. PubMed ID: 2464793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma].
    Arima N; Mizoguchi H; Shirakawa S; Tomonaga M; Takatsuki K; Ohno R
    Gan To Kagaku Ryoho; 1999 Apr; 26(5):619-29. PubMed ID: 10234292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor lysis syndrome induced by fludarabine monophosphate: a case report.
    Nakhoul F; Green J; Abassi ZA; Carter A
    Eur J Haematol; 1996 Apr; 56(4):254-5. PubMed ID: 8641396
    [No Abstract]   [Full Text] [Related]  

  • 19. Astrovirus enteritis in a chronic lymphocytic leukemia patient treated with fludarabine monophosphate.
    Coppo P; Scieux C; Ferchal F; Clauvel J; Lassoued K
    Ann Hematol; 2000 Jan; 79(1):43-5. PubMed ID: 10663621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine-related hemolytic anemia in chronic lymphocytic leukemia and lymphoproliferative disorders.
    Taha HM; Narasihman P; Venkatesh L; Cawley M; Kaplan B
    Am J Hematol; 1998 Dec; 59(4):316. PubMed ID: 9840913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.